Controlled Trials of Antibiotic Treatment in Patients with Post-Treatment Chronic Lyme Disease
- 1 December 2002
- journal article
- review article
- Published by Mary Ann Liebert Inc in Vector-Borne and Zoonotic Diseases
- Vol. 2 (4), 255-263
- https://doi.org/10.1089/153036602321653842
Abstract
Some patients have persistence of profound fatigue, myalgias, arthralgias without arthritis, dysesthesia/paresthesia, and mood and memory disturbances after standard courses of antibiotic treatment for Lyme disease. This constellation of symptoms has been variously referred to as "chronic Lyme disease," "post-Lyme disease syndrome," and "post-treatment chronic Lyme disease." Persistent symptoms have been reported in patients who are seropositive for IgG antibodies against Borrelia burgdorferi as well as in patients who are seronegative. The cause or causes of persistent symptoms in these patients have not been clearly defined and are controversial. Because of the temporal association of these symptoms with infection with B. burgdorferi, some patients have been treated with prolonged courses of antibiotics. Case reports and uncontrolled trials have reported the efficacy of prolonged antibiotic therapy, often with relapse of the symptoms after discontinuation of therapy. To date, only one randomized, placebo-controlled, double-blind trial of antibiotic therapy for these patients has been published. An abstract of a second placebo-controlled trial of antibiotic therapy in a smaller cohort has also been presented. This paper will describe this patient population in detail and will review the clinical, microbiological, and selected biochemical and immunologic parameters and their responses to antibiotic treatment in the setting of a controlled trial.Keywords
This publication has 10 references indexed in Scilit:
- Lyme DiseaseNew England Journal of Medicine, 2001
- Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme DiseaseNew England Journal of Medicine, 2001
- Direct enumeration ofBorrelia-reactive CD4 T cellsex vivoby using MHC class II tetramersProceedings of the National Academy of Sciences of the United States of America, 2000
- Practice Guidelines for the Treatment of Lyme DiseaseClinical Infectious Diseases, 2000
- Is it thee or me?—autoimmunity in Lyme diseaseNature Medicine, 1999
- The fibromyalgia impact questionnaire: A useful tool in evaluating patients with post-Lyme disease syndromeArthritis & Rheumatism, 1999
- Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Cerebrospinal Fluid in Lyme NeuroborreliosisThe Journal of Infectious Diseases, 1996
- The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsAnnals of Neurology, 1994
- Nerve growth factor-induced hyperalgesia in the neonatal and adult ratJournal of Neuroscience, 1993
- NGF receptor-mediated reduction in axonal NGF uptake and retrograde transport following sciatic nerve injury and during regenerationNeuron, 1991